Produit-Zengaffinen N, Davis-Lameloise N, Perreten H, Bécard D, Gjinovci A, Keller P A, Wollheim C B, Herrera P, Muzzin P, Assimacopoulos-Jeannet F
Department of Cell Physiology and Metabolism, Centre Médical Universitaire, 1 rue Michel Servet, CH 1211, Geneva 4, Switzerland.
Diabetologia. 2007 Jan;50(1):84-93. doi: 10.1007/s00125-006-0499-6. Epub 2006 Nov 28.
AIMS/HYPOTHESIS: Levels of uncoupling protein-2 (UCP2) are regulated in the pancreatic beta cells and an increase in the protein level has been associated with mitochondrial uncoupling and alteration in glucose-stimulated insulin secretion. However, it is not clear whether an increase in uncoupling protein-2 per se induces mitochondrial uncoupling and affects ATP generation and insulin secretion.
Transgenic mice with beta cell-specific overexpression of the human UCP2 gene and INS-1 cells with doxycycline-inducible overproduction of the protein were generated and the consequences of increased levels of UCP2 on glucose-induced insulin secretion and on parameters reflecting mitochondrial uncoupling were determined.
In transgenic mice, an increase in beta cell UCP2 protein concentration did not significantly modify plasma glucose and insulin levels. Glucose-induced insulin secretion and elevation in the ATP/ADP ratio were unaltered by an increase in UCP2 level. In INS-1 cells, a similar increase in UCP2 level did not modify glucose-induced insulin secretion, cytosolic ATP and ATP/ADP ratio, or glucose oxidation. Increased levels of UCP2 did not modify the mitochondrial membrane potential and oxygen consumption. Increased UCP2 levels decreased cytokine-induced production of reactive oxygen species.
CONCLUSION/INTERPRETATION: The results obtained in transgenic mice and in the beta cell line do not support the hypothesis that an increase in UCP2 protein per se uncouples the mitochondria and decreases glucose-induced insulin secretion. In contrast, the observation that increased UCP2 levels decrease cytokine-induced production of reactive oxygen species indicates a potential protective effect of the protein on beta cells, as observed in other cell types.
目的/假设:解偶联蛋白2(UCP2)的水平在胰腺β细胞中受到调节,该蛋白水平的升高与线粒体解偶联以及葡萄糖刺激的胰岛素分泌改变有关。然而,尚不清楚解偶联蛋白2本身的增加是否会诱导线粒体解偶联并影响ATP生成和胰岛素分泌。
构建了β细胞特异性过表达人UCP2基因的转基因小鼠以及多西环素诱导型过量表达该蛋白的INS-1细胞,并确定了UCP2水平升高对葡萄糖诱导的胰岛素分泌以及反映线粒体解偶联参数的影响。
在转基因小鼠中,β细胞UCP2蛋白浓度的增加并未显著改变血糖和胰岛素水平。UCP2水平的升高未改变葡萄糖诱导的胰岛素分泌以及ATP/ADP比值的升高。在INS-1细胞中,UCP2水平的类似升高并未改变葡萄糖诱导的胰岛素分泌、胞质ATP和ATP/ADP比值或葡萄糖氧化。UCP2水平的升高未改变线粒体膜电位和氧消耗。UCP2水平的升高降低了细胞因子诱导的活性氧生成。
结论/解读:在转基因小鼠和β细胞系中获得的结果不支持UCP2蛋白本身增加会使线粒体解偶联并降低葡萄糖诱导的胰岛素分泌这一假设。相反,UCP2水平升高会降低细胞因子诱导的活性氧生成这一观察结果表明,该蛋白对β细胞具有潜在的保护作用,这与在其他细胞类型中观察到的情况一致。